Correlation Between CLS Holdings and Petros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both CLS Holdings and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CLS Holdings and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CLS Holdings USA and Petros Pharmaceuticals, you can compare the effects of market volatilities on CLS Holdings and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CLS Holdings with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CLS Holdings and Petros Pharmaceuticals.

Diversification Opportunities for CLS Holdings and Petros Pharmaceuticals

-0.34

Correlation Coefficient

CLS Holdings  Petros Pharmaceuticals

Very good diversification

The 3 months correlation between CLS and Petros is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding CLS Holdings USA and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and CLS Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CLS Holdings USA are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of CLS Holdings i.e., CLS Holdings and Petros Pharmaceuticals go up and down completely randomly.

Pair Corralation between CLS Holdings and Petros Pharmaceuticals

Given the investment horizon of 90 days CLS Holdings USA is expected to under-perform the Petros Pharmaceuticals. But the otc stock apears to be less risky and, when comparing its historical volatility, CLS Holdings USA is 1.35 times less risky than Petros Pharmaceuticals. The otc stock trades about -0.27 of its potential returns per unit of risk. The Petros Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  31.00  in Petros Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of  4.00  from holding Petros Pharmaceuticals or generate 12.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CLS Holdings USA  vs.  Petros Pharmaceuticals

CLS Holdings USA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CLS Holdings USA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Petros Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Petros Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Petros Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CLS Holdings and Petros Pharmaceuticals

The main advantage of trading using opposite CLS Holdings and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CLS Holdings position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.

The idea behind CLS Holdings USA and Petros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.